US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

ARTL Artelo Biosciences Inc

1.34

-0.05 (-3.60%)

10 May 2024 - Cerrado

Retrasado por 15 minutos

Form EFFECT - Notice of Effectiveness

Artelo Biosciences (NASDAQ:ARTL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Artelo Biosciences.

Artelo Biosciences (NASDAQ:ARTL)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Artelo Biosciences.

Noticias sobre Artelo Biosciences Inc ARTL

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
Viernes 10 de Mayo 2024 (18 horas hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Martes 23 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Lunes 22 de Abril 2024 (3 semanas hace) • GlobeNewswire Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Lunes 25 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Martes 12 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Martes 23 de Enero 2024 (4 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Lunes 8 de Enero 2024 (4 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Martes 5 de Diciembre 2023 (5 meses hace) • GlobeNewswire Inc.

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Jueves 30 de Noviembre 2023 (5 meses hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 13 de Noviembre 2023 (6 meses hace) • Edgar (US Regulatory)

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Lunes 13 de Noviembre 2023 (6 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Jueves 9 de Noviembre 2023 (6 meses hace) • GlobeNewswire Inc.

Más de Artelo Biosciences Inc Artículos de Noticias

American Express

JP Morgan Chase

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones